53
GAMBARDELLA, A; AGUGLIA, U; CHIFARI, R; LABATE, A; MANNA, I; SERRA, P;
ROMEO, N; SIBILIA, G; LEPIANE, E; RUSSA, AL; VENTURA, P; CITTADELLA, R;
SASANELLI, F; COLOSIMO, E; LEGGIO, U; ZAPPIA, M; QUATTRONE, A. APOE
epsilon4 allele and disease duration affect verbal learning in mild temporal lobe
epilepsy. Epilepsia., [S.l.], v. 46, n. 1, p. 110-117, 2005.
GUERRERO, AL; LAHERRAN, E; GUTIERREZ, F; MARTIN-POLO, J; IGLESIAS, F;
ALCAZAR, C; PERALTA, J; ROSTAMI, P. Apolipoprotein E genotype does not
associate with disease severity measured by Multiple Sclerosis Severity Score. Acta
Neurol Scand., [S.l.], v. 117, n. 1, p. 21-25, 2008.
HENSIEK, AE; SEAMAN, SR; BARCELLOS, LF; OTURAI, A; ERAKSOI, M; COCCO,
E; VECSEI, L; STEWART, G; DUBOIS, B; BELLMAN-STROBL, J; LEONE, M;
ANDERSEN, O; BENCSIK, K; BOOTH, D; CELIUS, EG; HARBO, HF; HAUSER, SL;
HEARD, R; HILLERT, J; MYHR, KM; MARROSU, MG; OKSENBERG, JR; RAJDA,
C; SAWCER, SJ; SØRENSEN, PS; ZIPP, F; COMPSTON, DA. Familial effects on
the clinical course of multiple sclerosis. Neurology., [S.l.], v. 68, n. 5, p. 376-383,
2007.
KALMAN, B; LUBLIN, FD. The genetics of Multiple Sclerosis. A review. Biomed
Pharmacother., [S.l.], v. 53, n. 8, p. 358-370, 1999.
KANTARCI, OH; DE ANDRADE, M; WEINSKENKER, BG. Identifying disease
modifying genes in multiple sclerosis. J Neuroimmunol., [S.l.], v. 123, n. 1-2, p. 144-
159, 2002.
KLAGES, JD; FISK, JD; ROCKWOOD, K. APOE genotype, memory test
performance, and the risk of Alzheimer’s disease in the Canadian Study of Health
and Aging. Dement Geriatr Cogn Disord., [S.l.], v. 15, n. 1, p. 1-5, 2003.
KOUTSIS, G; PANAS, M; GIOGKARAKI, E; POTAGAS, C; KARADIMA, G;
SFAGOS, C; VASSILOPOULOS, D. APOE epsilon4 is associated with impaired
verbal learning in patients with MS. Neurology., [S.l.], v. 68, n. 8, p. 546-549, 2007.
KOUTSIS, G; PANAS, M; KARADIMA, G; MANDELLOS, D; SFAGOS, C;
POTAGAS, C; VASSILOPOULOS, D. APOE genotypes in Greek multiple sclerosis
patients: no effect on the MS Severity Score. J Neurol., [S.l.], v. 254, n. 3, p. 394-395,
2007.
KURTZKE, JF. Rating neurologic impairment in multiple sclerosis: an expanded
disability status scale (EDSS). Neurology., [S.l.], v. 33, n. 11, p. 1444-1452, 1983.